Looking at the entire industry, the current production of pharmaceutical intermediates in China has six characteristics:

First, most of the production enterprises are private enterprises, flexible in operation, and the investment scale is not large, basically between millions and 120 million yuan; Second, the geographical distribution of production enterprises is relatively concentrated, mainly distributed in the areas centered on Taizhou, Zhejiang and Jintan, Jiangsu; Third, with the country's increasing attention to environmental protection issues, the pressure on production enterprises to build environmental protection treatment facilities has increased; Fourth, the product update speed is fast. After a product is generally on the market for 3~5 years, its profit margin will drop significantly, which forces enterprises to continuously develop new products or continuously improve production processes in order to maintain high production profits; Fifth, because the production profit of pharmaceutical intermediates is higher than that of chemical products, and the production process of the two is basically the same, more and more small chemical enterprises have joined the ranks of producing pharmaceutical intermediates, resulting in increasingly disorderly competition in the industry; Sixth, compared with APIs, the profit margin of the production of intermediates is low, and the production process of APIs and pharmaceutical intermediates is similar, so some companies have not only produced intermediates, but also used their own advantages to start producing APIs.